Literature DB >> 20547820

Epinephrine injection in lipid-based resuscitation from bupivacaine-induced cardiac arrest: transient circulatory return in rabbits.

Martyn Harvey1, Grant Cave, Gaynor Prince, Daniel Lahner.   

Abstract

BACKGROUND: IV lipid emulsion has demonstrated to be effective therapy for bupivacaine-induced cardiotoxicity. However, the role of epinephrine when coadministered with lipid emulsion in toxin-induced cardiac arrest is unclear. We postulated superior resuscitation outcome in the absence of epinephrine in a rabbit model of bupivacaine-induced cardiac arrest resuscitated with IV lipid emulsion.
METHODS: Twenty sedated, instrumented New Zealand White rabbits received 10 mg/kg IV bupivacaine producing asystole. Mechanical ventilation and external chest compressions were commenced at 30 seconds. At 1 minute, animals received 5 mL/kg 20% lipid emulsion in addition to 1 of 4 additional IV treatments (n = 5 all groups): 0.9% saline, 2.5 microg/kg epinephrine, 10 microg/kg epinephrine, 100 microg/kg epinephrine; all at 1 mL/kg. Lipid emulsion bolus was repeated at 4 minutes. Return of spontaneous circulation and hemodynamic metrics were obtained to 15 minutes. Saline group animals additionally received high-dose epinephrine (100 microg/kg) treatment at 15 minutes, and were monitored to 20 minutes.
RESULTS: High-dose epinephrine administration was associated with increased rate of return of spontaneous circulation compared with saline control (0 of 5 saline-treated animals; 0 of 5 animals in the 2.5 microg/kg epinephrine group; 3 of 5 in the 10 microg/kg group [P = 0.167]; and 4 of 5 in the 100 microg/kg group [P = 0.048]). Spontaneous but decreasing circulation was maintained at 15 minutes in 4 of 5 animals in the 100 microg/kg group alone (P = 0.048); mean arterial blood pressure at 15 minutes was 12.8 (SEM 2.8) mm Hg saline, 12.0 (2.5) mm Hg 2.5 microg/kg epinephrine, 20.6 (2.7) mm Hg 10 microg/kg epinephrine, and 26.4 (3.9) mm Hg 100 microg/kg epinephrine (P = 0.008). Four of five animals in the saline-treated group exhibited return of spontaneous circulation after delayed epinephrine treatment (P = 0.048). High-dose epinephrine administration was associated with a significant increase in coronary perfusion pressure before return of spontaneous circulation.
CONCLUSIONS: Epinephrine seemed to be necessary for return of spontaneous circulation, but was subsequently associated with declining hemodynamic variables in this rabbit model of bupivacaine-induced cardiac arrest. Further study is required to define the role of epinephrine in lipid-based resuscitation from local anesthetic-induced cardiac arrest.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547820     DOI: 10.1213/ANE.0b013e3181e66050

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Resuscitation with lipid emulsion: dose-dependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect.

Authors:  Michael R Fettiplace; Belinda S Akpa; Richard Ripper; Brian Zider; Jason Lang; Israel Rubinstein; Guy Weinberg
Journal:  Anesthesiology       Date:  2014-04       Impact factor: 7.892

2.  Epinephrine reversed high-concentration bupivacaine-induced inhibition of calcium channels and transient outward potassium current channels, but not on sodium channel in ventricular myocytes of rats.

Authors:  Fuli Liu; Bingjing Wu; Yongjun Du; Yiquan Wu; Hongfei Chen; Fangfang Xia; Zhousheng Jin; Xuzhong Xu
Journal:  BMC Anesthesiol       Date:  2015-04-30       Impact factor: 2.217

3.  Levosimendan combined with epinephrine improves rescue outcomes in a rat model of lipid-based resuscitation from bupivacaine-induced cardiac arrest.

Authors:  Fubei Nan; Xixi Cai; Yingchao Ye; Xuzhong Xu; Zhengqian Li; Min Li; Limei Chen
Journal:  BMC Anesthesiol       Date:  2017-09-15       Impact factor: 2.217

4.  Lipid emulsions enhance the norepinephrine-mediated reversal of local anesthetic-induced vasodilation at toxic doses.

Authors:  Soo Hee Lee; Hui-Jin Sung; Seong-Ho Ok; Jongsun Yu; Mun-Jeoung Choi; Jin Soo Lim; Ju-Tae Sohn
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.